Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

NCT00137345 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplant

Interventions

DRUG: sirolimus

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer